Literature DB >> 24224626

Clinical practice: Adult attention deficit-hyperactivity disorder.

Nora D Volkow, James M Swanson.   

Abstract

Short-term trials involving adults with ADHD have shown significant improvements in symptoms with stimulants and atomoxetine; however, data on long-term benefits and risks of these medications, particularly among older persons, have been insufficient.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24224626      PMCID： PMC4827421          DOI： 10.1056/NEJMcp1212625

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


  45 in total

1.  ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.

Authors:  Laurel A Habel; William O Cooper; Colin M Sox; K Arnold Chan; Bruce H Fireman; Patrick G Arbogast; T Craig Cheetham; Virginia P Quinn; Sascha Dublin; Denise M Boudreau; Susan E Andrade; Pamala A Pawloski; Marsha A Raebel; David H Smith; Ninah Achacoso; Connie Uratsu; Alan S Go; Steve Sidney; Mai N Nguyen-Huynh; Wayne A Ray; Joe V Selby
Journal:  JAMA       Date:  2011-12-12       Impact factor: 56.272

Review 2.  The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics.

Authors:  Edmund J S Sonuga-Barke
Journal:  Neurosci Biobehav Rev       Date:  2003-11       Impact factor: 8.989

3.  The mystery of missing heritability: Genetic interactions create phantom heritability.

Authors:  Or Zuk; Eliana Hechter; Shamil R Sunyaev; Eric S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-05       Impact factor: 11.205

Review 4.  Systematic review of national and international guidelines on attention-deficit hyperactivity disorder.

Authors:  Miguel Seixas; Margaret Weiss; Ulrich Müller
Journal:  J Psychopharmacol       Date:  2011-09-24       Impact factor: 4.153

5.  The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder.

Authors:  Russell A Barkley; Mariellen Fischer; Lori Smallish; Kenneth Fletcher
Journal:  J Abnorm Psychol       Date:  2002-05

6.  Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.

Authors:  James J McGough; Susan L Smalley; James T McCracken; May Yang; Melissa Del'Homme; Deborah E Lynn; Sandra Loo
Journal:  Am J Psychiatry       Date:  2005-09       Impact factor: 18.112

Review 7.  Cognitive behavior therapy for adults with attention-deficit/hyperactivity disorder: a review of recent randomized controlled trials.

Authors:  Monica Mongia; Lily Hechtman
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

8.  Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder.

Authors:  Tanya E Froehlich; Bruce P Lanphear; Peggy Auinger; Richard Hornung; Jeffery N Epstein; Joe Braun; Robert S Kahn
Journal:  Pediatrics       Date:  2009-11-23       Impact factor: 7.124

Review 9.  Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.

Authors:  Mats Fredriksen; Anne Halmøy; Stephen V Faraone; Jan Haavik
Journal:  Eur Neuropsychopharmacol       Date:  2012-08-20       Impact factor: 4.600

10.  The IMAGE project: methodological issues for the molecular genetic analysis of ADHD.

Authors:  Jonna Kuntsi; Benjamin M Neale; Wai Chen; Stephen V Faraone; Philip Asherson
Journal:  Behav Brain Funct       Date:  2006-08-03       Impact factor: 3.759
View more
  42 in total

1.  Comparison of the VTA and LC response to methylphenidate: a concomitant behavioral and neuronal study of adolescent male rats.

Authors:  Tahseen J Karim; Cruz Reyes-Vazquez; Nachum Dafny
Journal:  J Neurophysiol       Date:  2017-06-14       Impact factor: 2.714

2.  Transcranial direct current brain stimulation decreases impulsivity in ADHD.

Authors:  Cheyenne Allenby; Mary Falcone; Leah Bernardo; E Paul Wileyto; Anthony Rostain; J Russell Ramsay; Caryn Lerman; James Loughead
Journal:  Brain Stimul       Date:  2018-04-23       Impact factor: 8.955

Review 3.  Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.

Authors:  Howard M Kravitz; Robert S Katz
Journal:  Rheumatol Int       Date:  2015-01-13       Impact factor: 2.631

4.  Combining Stimulants and Monoamine Oxidase Inhibitors: A Reexamination of the Literature and a Report of a New Treatment Combination.

Authors:  Joshua A Israel
Journal:  Prim Care Companion CNS Disord       Date:  2015-12-10

Review 5.  Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder.

Authors:  Cristian Bonvicini; Stephen V Faraone; Catia Scassellati
Journal:  World J Biol Psychiatry       Date:  2017-02-24       Impact factor: 4.132

Review 6.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

7.  Comparison of pregnancy and lactation labeling for attention-deficit hyperactivity disorder drugs marketed in Australia, the USA, Denmark, and the UK.

Authors:  Pernille Warrer; Lise Aagaard; Ebba Holme Hansen
Journal:  Drug Saf       Date:  2014-10       Impact factor: 5.606

8.  Timing of the Diagnoses of Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder in Taiwan.

Authors:  Han-Ting Wei; Ju-Wei Hsu; Kai-Lin Huang; Ya-Mei Bai; Tung-Ping Su; Cheng-Ta Li; Wei-Chen Lin; Shih-Jen Tsai; Tai-Long Pan; Tzeng-Ji Chen; Mu-Hong Chen
Journal:  J Autism Dev Disord       Date:  2021-03

9.  Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial.

Authors:  E Hoxhaj; C Sadohara; P Borel; R D'Amelio; E Sobanski; H Müller; B Feige; S Matthies; Alexandra Philipsen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-01-22       Impact factor: 5.270

Review 10.  A systematic review of transcranial direct current stimulation effects in attention-deficit/hyperactivity disorder.

Authors:  Camila Cosmo; Melany DiBiasi; Vania Lima; Luanda Collange Grecco; Mauro Muszkat; Noah S Philip; Eduardo Pondé de Sena
Journal:  J Affect Disord       Date:  2020-07-14       Impact factor: 4.839
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.